Prospects Of World Wide Stem Cell Therapy Industry In 2027
Stem cell therapy also known as regenerative medicine is considered to transform the healthcare industry a few years from now. Stem cells can renew themselves through mitotic cell division and differentiate into a wide range of specialized cell types.
The Market Potential Of Stem Cell Therapy Industry – An Overview
The stem cell therapy market was valued at US$ 1,534 million in 2019. It is estimated to reach US$ 18 billion by the end of 2028. It is expected to grow at a Compound Annual Growth Rate (CAGR) of 16.7% from 2020 to 2027.
With potential treatment procedures undergoing clinical trials and a noticiable number of stem cell therapies, having won FDA (Food and Drug Administration) approval for clinical usage is expected to fuel the growth of the stem cell therapy market.
Key Factors That Are Driving The Growth Of The Global Stem Cell Therapy Industry
- Increasing aging population,
- Grwoing disease awareness,
- Grwoing awareness about side-effects of conventional medicines,
- Increasing incidences of viral and other diseases such as cancer, corona, cardiac abnormalities, organ failures etc
- Development of banking facilities and resultant enhancement of stem cell production, storage and characterization.
The Division Of Global Stem Cell Therapy Market Based On Types-
- Therapy type,
- Therapeutic area,
- Cell type,
- End-user,
- Region.
The Region Wise Share Of The Stem Cell Therapy Industry-
Adult stem cell therapy held the largest market share of the market in 2020. The induced pluripotent stem cell therapy is estimated to register the highest CAGR in the market.